
Chemical and Pharmaceutical Bulletin p. 84 - 96 (1998)
Update date:2022-08-05
Topics:
Seki, Toshimi
Kanada, Arihiro
Nakao, Tomio
Shiraiwa, Masahumi
Asano, Hajime
Miyazawa, Katuhiko
Ishimori, Tsutomu
Minami, Nobuyoshi
Shibata, Kenyu
Yasuda, Kikuo
Synthesis of the four optical isomers of TZC-5665 (1), a candidate for the treatment of congestive heart failure, was achieved by the reaction of chiral diaminopyridazinone (2) with chiral glycidyl ether (3). The hypotensive and β-blocking activities of 1 and its optical isomers were examined when given intravenously into anesthetized rats. Furthermore these compounds were evaluated for inhibitory activity on cAMP phosphodiesterase III. Among the four optical isomers, R(A),S(B)-one (1c) possessed the essential activities of TZC-5665 (1).
View MoreShandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
hangzhou sunchem trading co., ltd.
Contact:13588470430--
Address:Room 406-407, the 4th Building, No549
Huangshi Shennong Chemical Technology Co., Ltd
Contact:+86-714-3072290
Address:Eastern industrial park , Tieshan district , Huangshi city ,Hubei province , China
Shanghai birch chemical technology co.,ltd
Contact:+86-21-54096810
Address:No.2588,Jungong Road,Shanghai,China
Contact:86 21 3772 9386
Address:Rm.1803,Starry Bldg.1,1505 Meijiabang Road,Shanghai 201620 China
Doi:10.1021/ja01083a022
(1965)Doi:10.1002/hlca.19680510627
(1968)Doi:10.1021/jo971995f
(1998)Doi:10.1002/anie.201304691
(2013)Doi:10.1039/a707354b
(1998)Doi:10.1016/S0957-4166(97)00617-4
(1998)